News
1h
Barchart on MSNThis Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip?Psychedelic stocks are gaining attention as new ways to treat mental illnesses like depression and post-traumatic stress disorder (PTSD). Companies in the niche use substances like psilocybin to ...
Tesla stock has declined 20% year to date amid disappointing financial results and substantial market share losses. Among ...
The partnership between OpenAI and Microsoft in many ways hinges on the definition of artificial general intelligence, ...
Production designer Chae Kyoung-sun shares her secrets behind the hit Netflix K-drama and how she teased the finale in her ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” first quarter 2025 ...
Today, most Wall Street analysts see the stock as overvalued. The median target price is $110 per share, which implies 23% ...
Stablecoins are poised to grow to trillions of dollars, and financial services giant and banks want a piece of it, says Zach ...
The more informed someone is, the more prone they are to allow short-term turbulence to distort their perception of the undeniable, unrelenting long-term trend. To be sure, not all journalists are ...
These three growth stocks give you exposure to the AI supply chain and cloud security, and all three are rated "Strong Buys" ...
Trump's shocking threat sends dollar plummeting to 3-year lows as markets panic. What he's planning will change everything ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results